JAKAVI (Ruxolitinib) 20mg x 30 Tablets

JAKAVI (Ruxolitinib) 20mg x 30 Tablets

JAKAVI, containing the active ingredient Ruxolitinib, is a medication used for the treatment of certain conditions related to the immune system and blood disorders. It is primarily indicated for patients with myelofibrosis and polycythemia vera.

Mechanism of Action

Ruxolitinib is a Janus kinase (JAK) inhibitor that works by blocking the activity of specific enzymes involved in the signaling pathways that contribute to the growth and activation of blood cells. This helps to reduce inflammation and control the symptoms associated with these conditions.

Indications

• Myelofibrosis
• Polycythemia Vera

Dosage and Administration

JAKAVI is typically taken orally, with or without food. Dosage is determined by a healthcare professional based on the patient's condition and response to treatment. It is important to follow the prescribed dosage and schedule.

Potential Side Effects

Like all medications, JAKAVI may cause side effects. Common side effects include:

• Increased risk of infections
• Headache
• Dizziness
• Elevated liver enzymes

Patients should report any unusual symptoms or side effects to their healthcare provider promptly.

Precautions

Before starting treatment with JAKAVI, inform your doctor about any existing medical conditions, particularly:

• History of infections
• Liver problems
• Low blood cell counts

Regular monitoring may be required during treatment to ensure safety and effectiveness.

Storage Instructions

Store JAKAVI at room temperature, away from moisture and heat. Keep out of reach of children.

Consultation

Always consult your healthcare provider for personalized advice and before starting any new medication, including JAKAVI.